Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Genetic Toxicology Testing Market Size, Share, Trends, Competitive Landscape, and Forecast - 2033 | $3.6 Billion Opportunity Fueled by Automation and Outsourcing

globenewswire.com
TMO Mentioned as a key player investing in research and laboratory expansion within the growing genetic toxicology testing market. SHIM Named as a key player in the genetic toxicology testing market, implying its role in the industry's growth and technological advancements. LAB Included as a key player in the genetic toxicology testing market, indicating its contribution to the sector's development. DHR Mentioned as a key player in the genetic toxicology testing market, suggesting its involvement in the industry's growth and innovation. ILMN Listed as a key player in the genetic toxicology testing market, indicating its role in the sector's expansion and technological advancements. QGEN Identified as a key player in the genetic toxicology testing market, suggesting its participation in the sector's growth and development. CRL Named as a key player in the genetic toxicology testing market, implying its contribution to the industry's growth and service offerings.

Global Genetic Toxicology Testing Market Size, Share, Trends, Competitive Landscape, and Forecast - 2033 | $3.6 Billion Opportunity Fueled by Automation and Outsourcing Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Genetic Toxicology Testing Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.

The global Genetic Toxicology Testing Market is projected to grow from USD 1.8 billion in 2026 to USD 3.6 billion by 2033, registering a compound annual growth rate (CAGR) of 10.20% during the forecast period. Market expansion is being supported by stricter regulatory requirements, growing pharmaceutical and biotechnology research pipelines, increased outsourcing, and continued advances in safety assessment technologies.

Demand for genetic toxicology testing is rising across the pharmaceutical, biotechnology, chemical, food, cosmetics, and agriculture industries. Manufacturers rely on validated in vitro and in vivo assays to identify potential genetic mutations, chromosomal abnormalities, and DNA damage before products enter clinical development or reach consumers. Early detection of genotoxic risks can help organizations improve product safety, streamline regulatory submissions, limit development costs, and reduce long-term commercial exposure.

Market Insights

Genetic toxicology testing remains an important part of preclinical safety evaluation. Its adoption is increasing as pharmaceutical and biotechnology companies pursue more complex biologics, gene therapies, targeted treatments, and novel drug candidates. These expanding development pipelines require accurate toxicological data to support regulatory review and informed decision-making.

Contract research organizations are also strengthening the market by providing specialized testing expertise, laboratory capacity, and regulatory support. Outsourcing allows product developers to access established platforms while concentrating internal resources on core research and commercialization priorities.

Automation, high-throughput screening, enhanced assay sensitivity, molecular diagnostics, and advanced genomic tools are improving laboratory efficiency and data reliability. These technologies can shorten turnaround times, support larger sample volumes, and provide more comprehensive safety assessments.

Key Market Drivers and Business Opportunities

Stringent global regulations remain a primary growth driver. Regulatory authorities require comprehensive genotoxicity data for many drugs, chemicals, food ingredients, and consumer products, encouraging manufacturers to use standardized and validated testing methods.

Investment in research and development is another major contributor. Pharmaceutical and biotechnology companies continue to develop therapies for chronic diseases, rare disorders, and emerging health threats, creating consistent demand for testing products and services. Environmental safety concerns and greater awareness of chemical exposure risks are further extending applications beyond healthcare.

Significant opportunities are emerging in alternative in vitro methods that reduce animal usage. Ethical considerations, scientific innovation, and evolving regulatory preferences are encouraging assay developers and testing laboratories to expand their non-animal testing capabilities.

Emerging economies also offer growth potential as pharmaceutical manufacturing expands and regulatory frameworks mature. Regional laboratories, local partnerships, and investments in Asia-Pacific, Latin America, and the Middle East can help providers serve growing customer bases and respond efficiently to local requirements.

Regional Analysis

North America holds a significant share of the Genetic Toxicology Testing Market due to its advanced research infrastructure, established healthcare systems, strict regulatory oversight, and concentration of pharmaceutical companies and testing providers.

Europe remains a major market, supported by rigorous product safety standards, environmental protection initiatives, and sustained investment in scientific research. Asia-Pacific is expected to record the fastest growth through 2033, driven by rapid industrialization, expanding pharmaceutical production, and increased biotechnology investment. China, India, and Japan are strengthening their research and laboratory capabilities, opening new opportunities for domestic and international providers.

Latin America and the Middle East & Africa are gradually increasing their adoption of standardized toxicology testing as healthcare infrastructure improves and regulatory awareness grows.

Key Players

Leading companies are investing in research, laboratory expansion, automated platforms, and strategic collaborations to improve service capacity and strengthen their competitive positions.

Key Topics Covered

1. Executive Summary

1.1. Global Genetic Toxicology Testing Market Snapshot

1.2. Future Projections

1.3. Key Market Trends

1.4. Regional Snapshot, by Value, 2026

1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations

2.2. Market Dynamics

2.2.1. Drivers

2.2.2. Restraints

2.2.3. Market Opportunities

2.3. Value Chain Analysis

2.4. COVID-19 Impact Analysis

2.5. Porter's Five Forces Analysis

2.6. Impact of Russia-Ukraine Conflict

2.7. PESTLE Analysis

2.8. Regulatory Analysis

2.9. Price Trend Analysis

2.9.1. Current Prices and Future Projections, 2025-2033

2.9.2. Price Impact Factors

3. Global Genetic Toxicology Testing Market Outlook, 2020-2033

3.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

3.1.1. Reagents & Consumables

3.1.2. Assays

3.1.3. Services

3.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

3.2.1. Healthcare Industry (Pharmaceutical & Biotechnology)

3.2.2. Food Industry

3.2.3. Cosmetics Industry

3.2.4. Other Industries (Agriculture and Chemical)

3.3. Market Outlook, by Region, Value (US$ Bn), 2020-2033

3.3.1. North America

3.3.2. Europe

3.3.3. Asia-Pacific

3.3.4. Latin America

3.3.5. Middle East & Africa

4. North America Genetic Toxicology Testing Market Outlook, 2020-2033

4.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

4.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

4.3. Market Outlook, by Country, Value (US$ Bn), 2020-2033

4.3.1. U.S. Market Outlook, by Product and Application, 2020-2033

4.3.2. Canada Market Outlook, by Product and Application, 2020-2033

4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Genetic Toxicology Testing Market Outlook, 2020-2033

5.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

5.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

5.3. Market Outlook, by Country, Value (US$ Bn), 2020-2033

5.3.1. Germany Market Outlook, by Product and Application, 2020-2033

5.3.2. Italy Market Outlook, by Product and Application, 2020-2033

5.3.3. France Market Outlook, by Product and Application, 2020-2033

5.3.4. U.K. Market Outlook, by Product and Application, 2020-2033

5.3.5. Spain Market Outlook, by Product and Application, 2020-2033

5.3.6. Russia Market Outlook, by Product and Application, 2020-2033

5.3.7. Rest of Europe Market Outlook, by Product and Application, 2020-2033

5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia-Pacific Genetic Toxicology Testing Market Outlook, 2020-2033

6.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

6.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

6.3. Market Outlook, by Country, Value (US$ Bn), 2020-2033

6.3.1. China Market Outlook, by Product and Application, 2020-2033

6.3.2. Japan Market Outlook, by Product and Application, 2020-2033

6.3.3. South Korea Market Outlook, by Product and Application, 2020-2033

6.3.4. India Market Outlook, by Product and Application, 2020-2033

6.3.5. Southeast Asia Market Outlook, by Product and Application, 2020-2033

6.3.6. Rest of Asia-Pacific Market Outlook, by Product and Application, 2020-2033

6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Genetic Toxicology Testing Market Outlook, 2020-2033

7.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

7.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

7.3. Market Outlook, by Country, Value (US$ Bn), 2020-2033

7.3.1. Brazil Market Outlook, by Product and Application, 2020-2033

7.3.2. Mexico Market Outlook, by Product and Application, 2020-2033

7.3.3. Argentina Market Outlook, by Product and Application, 2020-2033

7.3.4. Rest of Latin America Market Outlook, by Product and Application, 2020-2033

7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Genetic Toxicology Testing Market Outlook, 2020-2033

8.1. Market Outlook, by Product, Value (US$ Bn), 2020-2033

8.2. Market Outlook, by Application, Value (US$ Bn), 2020-2033

8.3. Market Outlook, by Country, Value (US$ Bn), 2020-2033

8.3.1. GCC Market Outlook, by Product and Application, 2020-2033

8.3.2. South Africa Market Outlook, by Product and Application, 2020-2033

8.3.3. Egypt Market Outlook, by Product and Application, 2020-2033

8.3.4. Nigeria Market Outlook, by Product and Application, 2020-2033

8.3.5. Rest of Middle East & Africa Market Outlook, by Product and Application, 2020-2033

8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company vs. Segment Heatmap

9.2. Company Market Share Analysis, 2025

9.3. Competitive Dashboard

9.4. Company Profiles

9.4.1. Thermo Fisher Scientific

9.4.2. PerkinElmer, Inc.

9.4.3. Agilent Technologies

9.4.4. Shimadzu Corporation

9.4.5. Bio-Rad Laboratories

9.4.6. Danaher Corporation

9.4.7. Illumina, Inc.

9.4.8. Qiagen N.V.

9.4.9. Charles River Laboratories

9.4.10. Eurofins Scientific

9.5. Company Profile Parameters

9.5.1. Company Overview

9.5.2. Product Portfolio

9.5.3. Financial Overview

9.5.4. Business Strategies and Developments

10. Appendix

10.1. Research Methodology

10.2. Report Assumptions

10.3. Acronyms and Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/aoz44u

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.